A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome
暂无分享,去创建一个
M. Stratton | B. Ponder | R. Wooster | M. Dowsett | R. Eeles | D. Easton | J. Mangion | P. Barrett-Lee | Simon A. Smith | D. Averill
[1] D. Thomas,et al. Breast cancer in men: risk factors with hormonal implications. , 1992, American journal of epidemiology.
[2] J. Griffin. Androgen resistance--the clinical and molecular spectrum. , 1992, The New England journal of medicine.
[3] D. Housman,et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.
[4] D. Housman,et al. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour , 1991, Nature.
[5] K. Fischbeck,et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.
[6] D. Thomas,et al. Breast cancer in men: aspects of familial aggregation. , 1991, Journal of the National Cancer Institute.
[7] J. Wilson,et al. Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. , 1991, The Journal of clinical investigation.
[8] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[9] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[10] R. W. Crichlow,et al. Male breast cancer. , 1990, The Surgical clinics of North America.
[11] G. Verdi,et al. Familial male breast carcinoma , 1990, Cancer.
[12] A. Auquier,et al. Risk factors for male breast cancer: A Franco‐Swiss case‐control study , 1990, International journal of cancer.
[13] K. Yamamoto,et al. Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. , 1989, Genes & development.
[14] P. Chambon,et al. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element , 1989, Nature.
[15] P. Chambon,et al. The N‐terminal DNA‐binding ‘zinc finger’ of the oestrogen and glucocorticoid receptors determines target gene specificity. , 1988, The EMBO journal.
[16] Rosenberg Dp. Endocrine epidemiology of male breast cancer (review). , 1988 .
[17] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[18] H. Bingham. Familial breast cancer in males , 1987 .
[19] J. Simpson,et al. Abnormal sexual differentiation and neoplasia. , 1987, Cancer genetics and cytogenetics.
[20] F. Kozak,et al. Familial breast cancer in males: A case report and review of the literature , 1986, Cancer.
[21] M. Frydman,et al. Uncomplicated familial hypospadias: evidence for autosomal recessive inheritance. , 1985, American journal of medical genetics.
[22] J. Forbes,et al. FAMILIAL MALE BREAST CANCER , 1976, The Lancet.
[23] J. Fraumeni,et al. FAMILIAL MALE BREAST CANCER , 1976, The Lancet.
[24] J. Fischer,et al. Breast cancer in brothers Case reports and a review of 30 cases of male breast cancer , 1975, Cancer.
[25] E. Harris. Genetic epidemiology of hypospadias. , 1990, Epidemiologic reviews.